Tissue Engineering and Stem Cell Research

  • Paolo De CoppiEmail author
Reference work entry


Congenital or acquired surgical conditions are associated to high morbidity and mortality, and most of the time functional replacement of the missing or damaged organ remains an unmet clinical need. Regenerative medicine has recently been established as an emerging interdisciplinary field focused on the repair, replacement, or regeneration of cells, tissues, or organs. So far, there has been success in the production and surgical replacement of organs such as the urethra, bladder, and trachea.

While regenerative medicine encompasses a number of different disciplines, when it is aimed toward organogenesis, the important components are appropriate cells and an appropriate scaffold. The employment of induced pluripotent cells may overcome the use of immunosuppression associated with embryonic stem cells. Moreover, amniotic fluid stem cells may be specifically relevant to the cure of congenital malformation and reduce the hazards associated with pluripotent cells such as tumorigenesis, rejection, difficulty in isolation, and ethical issues. Research on scaffold-cell interaction has indicated that beyond the need for suitable biomechanical properties and micro-architecture, an optimal scaffold must support cell-matrix signaling; decellularized scaffolds may hold an advantage toward this.

The success obtained so far in transplanting tissue-engineered structures has paved the way for the regeneration of more complex and solid organs. Herein, regenerative medicine could represent a valid solution to the shortage of donors for organ transplantation.


Regenerative medicine Stem cell Congenital malformation Tissue engineering Transplantation Organ decellularization 


  1. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet. 2006;367:1241–6. Scholar
  2. Badylak SF, et al. Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A. 2011;17:1643–50. Scholar
  3. Baptista PM, et al. The use of whole organ decellularization for the generation of a vascularized liver organoid. Hepatology. 2011;53:604–17. Scholar
  4. Barker N, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature. 2007;449:1003–7. Scholar
  5. Bejjani GK, Zabramski J, Durasis Study G. Safety and efficacy of the porcine small intestinal submucosa dural substitute: results of a prospective multicenter study and literature review. J Neurosurg. 2007;106:1028–33. Scholar
  6. Bhrany AD, et al. Development of an esophagus acellular matrix tissue scaffold. Tissue Eng. 2006;12:319–30. Scholar
  7. Campbell KH, McWhir J, Ritchie WA, Wilmut I. Sheep cloned by nuclear transfer from a cultured cell line. Nature. 1996;380:64–6. Scholar
  8. Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online. 2009;18(Suppl 1):17–27.CrossRefGoogle Scholar
  9. Champagne BJ, et al. Efficacy of anal fistula plug in closure of cryptoglandular fistulas: long-term follow-up. Dis Colon Rectum. 2006;49:1817–21. Scholar
  10. Choi RS, Vacanti JP. Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc. 1997;29:848–51.CrossRefGoogle Scholar
  11. Clough A, Ball J, Smith GS, Leibman S. Porcine small intestine submucosa matrix (Surgisis) for esophageal perforation. Ann Thorac Surg. 2011;91:e15–6. Scholar
  12. Dahl SL, et al. Readily available tissue-engineered vascular grafts. Sci Transl Med. 2011;3, 68ra69. Scholar
  13. De Coppi P. Regenerative medicine for congenital malformations. J Pediatr Surg. 2013;48:273–80. Scholar
  14. De Coppi P, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–6. Scholar
  15. Ditadi A, et al. Human and murine amniotic fluid c-kit+Lin- cells display hematopoietic activity. Blood. 2009;113:3953–60. Scholar
  16. Dunn JC. Is the tissue-engineered intestine clinically viable? Nat Clin Pract Gastroenterol Hepatol. 2008;5:366–7. Scholar
  17. Elliott MJ, et al. Stem-cell-based, tissue engineered tracheal replacement in a child: a 2-year follow-up study. Lancet. 2012. Scholar
  18. Fishman JM, et al. Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model. Proc Natl Acad Sci U S A. 2013;110:14360–5. Scholar
  19. Franklin Jr ME, et al. The use of porcine small intestinal submucosa as a prosthetic material for laparoscopic hernia repair in infected and potentially contaminated fields: long-term follow-up. Surg Endosc. 2008;22:1941–6. Scholar
  20. Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6:230–47.CrossRefGoogle Scholar
  21. Fuchs JR, et al. Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg. 2004; 39:834–8; discussion 834–8.CrossRefGoogle Scholar
  22. Grikscheit TC, et al. Tissue-engineered small intestine improves recovery after massive small bowel resection. Ann Surg. 2004;240:748–54.CrossRefGoogle Scholar
  23. Horwitz EM, et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999;5:309–13. Scholar
  24. Horwitz EM, et al. Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy. 2005;7:393–5. Scholar
  25. Jungebluth P, et al. Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study. Lancet. 2011;378:1997–2004. Scholar
  26. Kang HW, et al. A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat Biotechnol. 2016;34:312–9. Scholar
  27. Kim SS, et al. Regenerative signals for tissue-engineered small intestine. Transplant Proc. 1999;31:657–60.CrossRefGoogle Scholar
  28. Le Blanc K, et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation. 2005;79:1607–14.CrossRefGoogle Scholar
  29. Macchiarini P, Jungebluth P, Go T, Asnaghi MA, Rees LE, Cogan TA, Dodson A, Martorell J, Bellini S, Parnigotto PP, Dickinson SC, Hollander AP, Mantero S, Conconi MT, Birchall MA. Clinical transplantation of a tissue-engineered airway. Lancet. 2008;372(9655):2023–30.CrossRefGoogle Scholar
  30. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol. 2007;25:1177–81. Scholar
  31. Moschidou D, et al. Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach. Mol Ther. 2012. Scholar
  32. Ott HC, et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nat Med. 2008;14:213–21. Scholar
  33. Ott HC, et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med. 2010;16:927–33. Scholar
  34. Ozeki M, et al. Evaluation of decellularized esophagus as a scaffold for cultured esophageal epithelial cells. J Biomed Mater Res A. 2006;79:771–8. Scholar
  35. Piccoli M, et al. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model. Stem Cells. 2012;30:1675–84. Scholar
  36. Pittenger MF, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–7.CrossRefGoogle Scholar
  37. Raya-Rivera A, et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet. 2011;377:1175–82. Scholar
  38. Raya-Rivera AM, Esquiliano D, Fierro-Pastrana R, López-Bayghen E, Valencia P, Ordorica-Flores R, Soker S, Yoo JJ, Atala A.Tissue-engineered autologous vaginal organs in patients: a pilot cohort study. Lancet. 2014;384(9940):329–36.CrossRefGoogle Scholar
  39. Sala FG, Kunisaki SM, Ochoa ER, Vacanti J, Grikscheit TC. Tissue-engineered small intestine and stomach form from autologous tissue in a preclinical large animal model. J Surg Res. 2009;156:205–12. Scholar
  40. Shin’oka T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med. 2001;344:532–3. Scholar
  41. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76. Scholar
  42. Takahashi K, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–72. Scholar
  43. Taylor MS, Daniels AU, Andriano KP, Heller J. Six bioabsorbable polymers: in vitro acute toxicity of accumulated degradation products. J Appl Biomater. 1994;5:151–7. Scholar
  44. Thomson JA, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–7.CrossRefGoogle Scholar
  45. Totonelli G, et al. A rat decellularized small bowel scaffold that preserves villus-crypt architecture for intestinal regeneration. Biomaterials. 2012;33:3401–10. Scholar
  46. Totonelli G, et al. Detergent enzymatic treatment for the development of a natural acellular matrix for oesophageal regeneration. Pediatr Surg Int. 2013;29:87–95. Scholar
  47. Turner CG, et al. Preclinical regulatory validation of an engineered diaphragmatic tendon made with amniotic mesenchymal stem cells. J Pediatr Surg. 2011;46:57–61. Scholar
  48. Uygun BE, et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med. 2010;16:814–20. Scholar
  49. Uygun BE. et al. Decellularization and recellularization of whole livers. J Vis Exp. 2011.
  50. Voytik-Harbin SL, Brightman AO, Kraine MR, Waisner B, Badylak SF. Identification of extractable growth factors from small intestinal submucosa. J Cell Biochem. 1997;67:478–91.CrossRefGoogle Scholar
  51. Yu J, Thomson JA. Pluripotent stem cell lines. Genes Dev. 2008;22:1987–97. Scholar
  52. Yu J, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–20. Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Great Ormond Street Hospital and UCL Institute of Child HealthLondonUK

Personalised recommendations